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infections, varicocele, hypogonadotropic hypogonadism, chromosome 
abnormalities, and obstruction or agenesia of the seminal ducts. The 
study was designed in accordance with the Helsinki Declaration 
and its last modification (Tokyo 2004) on human experimentation, 
and it was approved by the Ethics Committees from Universidad 
Maimónides and the Centro de Estudios en Genética y Reproducción. 
Informed Consent was obtained from all patients. The diagnosis 
of azoospermia was established on the basis of the independent 
analysis of, at least, two semen samples collected 1 week apart. The 
serum concentrations of FSH  (normal range: 1.5–7  mIU ml−1), 
LH (normal range: 1.1–9 mIU ml−1), and testosterone (normal range: 
10–30 pmol ml−1) were measured and fell into the normal range in 
all patients. Azoospermic patients underwent a diagnostic testicular 
biopsy and sperm retrieval  (TESE) by microsurgery and agreed to 
provide a small piece of testicular tissue (5 mm in diameter) for research 
purposes. The testicular histopathology was categorized according to 
the most advanced degree of spermatogenesis, and the biopsies were 
classified either as HS (n = 5) or MA (n = 3), according to McLachlan 
et al. (2007).10 DAB (3,3’‑diaminobenzidine) immunohistochemistry 
was performed to localize DAZ family proteins and CDC25A in each 
biopsy. Negative controls were processed simultaneously by omitting 
the primary antibody or preabsorbing the primary antibody with 
specific synthetic peptides. Relative quantitation of gene expression by 
Real‑time PCR of the DAZ gene family and CDC25A was calculated 
using standard curves and normalized to actin in each sample.
Immunohistochemical analysis showed that in all biopsies with HS 
and MA, expression of DAZ was mainly detectable in the cytoplasm 
of spermatogonia clusters, near the basal lamina of the seminiferous 
tubules  (Figure 1a), and DAZL was detectable in the cytoplasm of 
some spermatogonia and spermatocytes (Figure 1b). BOULE and its 
downstream substrate CDC25A shared a similar pattern of expression 
in germ cell cytoplasm (Figure 1c and 1d). Interestingly, in one biopsy 
diagnosed with MA, no immunoexpression of both proteins was 
detected, but we were able to detect BOULE mRNA in this particular 
biopsy, suggesting that the translation of BOULE might be regulated 
by another RNA‑binding protein.
We did not found an association between the expression levels of 
the DAZ family genes analyzed by real‑time PCR with the diagnosis 
Dear Editor,
Infertility is a major health problem affecting 10%–15% of couples 
seeking to have children, and a male factor can be identified in about half 
of these cases.1 Nonobstructive azoospermia is one of the causes of male 
infertility (10%), resulting from testicular failure.2 The most common 
histological patterns in these patients are hypospermatogenesis (HS), 
maturation arrest (MA), and Sertoli cell‑only syndrome (SCO).3
The search for sensitive and specific markers of spermatogenesis 
that could better predict the sperm retrieval rates in patients with 
nonobstructive azoospermia can lead to improved management 
of male infertility. DAZ  (Deleted in Azoospermia) gene family has 
been extensively studied because the microdeletions containing DAZ 
genes in the Y chromosome are associated with a variety of testicular 
failures and impaired spermatogenesis.4–6 DAZ gene family consists 
of two autosomal genes, BOULE and DAZ‑L  (DAZ‑like), and the 
DAZ gene cluster on chromosome Y. These genetic factors encode for 
RNA‑binding proteins that are mainly expressed in germ cells and are 
considered essential for male fertility.5 Recently, the members of the cell 
cycle regulators CDC25 family were recognized as potential substrates 
for DAZ family proteins. Particularly, CDC25A is abundantly expressed 
in the testis and functions in the G1‑S transition and M‑phase exit, 
suggesting a role in mitotic or meiotic regulation of spermatogenesis.7–9 
The analysis of single DAZ gene has shown that its dysfunction 
leads to abnormal spermatogenesis and may cause infertility. They 
were, however, poorly associated to sperm recovery during assisted 
reproductive treatments. Whether the simultaneous expression of 
the members of the DAZ gene family and its substrates may provide 
better information of testicular damage and success of sperm recovery 
in infertile patients has not been yet analyzed.
We evaluated eight men  (29–38‑year‑old) with idiopathic 
infertility and nonobstructive azoospermia diagnosed by open 
testicular biopsy. None of these patients showed genitourinary 
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of the testicular pathology. No statistically significant differences 
between HS and MA pathologies were found when the DAZ family 
genes were analyzed individually; however, a positive correlation 
between the mRNA transcript ratios of DAZ gene family members 
and CDC25A was detected, irrespective of the testicular pathology. We 
found a statistically significant positive correlation for mRNA transcript 
ratios between DAZ and DAZ‑L  (r  =  0.9131 Pearson; P  =  0.0002), 
DAZ‑L and BOULE (r = 0.8163 Pearson; P = 0.0021), and DAZ and 
BOULE (r = 0.8484 Pearson; P = 0.0078). We also observed a positive 
correlation in the expression of DAZ‑L and BOULE with their testicular 
target CDC25A  (DAZ‑L/CDC25A r  =  0.8990 Pearson; P  =  0.0024; 
BOULE/CDC25A r = 0.9120 Pearson; P = 0.0016).
Finally, the infertile patients with testicular failure were divided into 
two groups according to the presence (success) or absence (failure) of 
sperm retrieval during TESE (Table 1). We found that irrespective of the 
testicular pathology, patients with success in sperm retrieval showed a 
statistically significant higher expression of DAZ, BOULE, and CDC25A, 
compared to patients with failure in sperm retrieval. These results suggest 
that DAZ family genes would be collectively rather than individually 
altered in patients with HS and MA. Since TESE is considered an invasive 
procedure with only 40%–60% success, the identification of molecular 
markers that can predict the presence of mature spermatozoa becomes 
a useful clinical tool. Although BOULE but its own shows conspicuous 
expression, our preliminary results pinpoint that the analysis of the 
expression level of BOULE together with DAZ, DAZ‑L, and their 
molecular target CDC25A could be used as a confident measure of the 
testicular damage and a more certain predictor of successful recovery of 
spermatozoa by TESE in pathological testicular biopsies.
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Table 1: Results of TESE and mRNA expression ratios of DAZ gene family and CDC25A of the infertile patients
Sperm retrieval group n DAZ mRNA ratio BOULE mRNA ratio DAZ‑L mRNA ratio CDC25A RNA ratio
Success 5 (HS=3, MA=2) 1.76±0.08a 12.43±6.09a 0.74±0.25 1.06±0.30a
Failure 3 (HS=2, MA=1) 0.01±0.006b 0.37±0.10b 0.03±0.02 0.01±0.001b
Values represent the mean±s.e.m. a,bSignificant differences between groups (Student’s t‑test, P<0.05). HS: hypospermatogenesis; MA: maturation arrest; s.e.m.: standard error of mean; 
TESE: testicular sperm extraction; DAZ: deleted in azoospermia
Figure 1: Immunolocalization of DAZ (a), DAZL (b), BOULE (c), and the cell‑cycle regulator CDC25A (d) in pathological testicular biopsies from patients with 
hypospermatogenesis (a and b) and maturation arrest (c and d). Note, DAZ cytoplasmic staining in the spermatogonia clusters (a) and DAZL staining in some 
spermatogonia and spermatocytes (b). BOULE was detected in the cytoplasm of the germ cells (c) in all biopsies and paralleled CDC25A immunostaining 
pattern (d). The arrows indicate immunopositive cells. ST: seminiferous tubules.
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